Alexis Hucteau PhD project

Logo

Notes about all the project advances and researches during the PhD

View the Project on GitHub AlexisHucteau/PhD_project

28.03.2022 - 01.04.2022 Week 13

28.03.2022

Looking at aracn effect on msviper TF activity prediction

Testing DeMAND-algorithm for Interrogating Drug Mechanism of Action using Network Dysregulation analysis

Using DeMAND, Mechanism of Action dyregulated NR vs R:

moaGene Pvalue FDR
NOS2 1.517842e-11 4.551391e-08
CYP17A1 2.937329e-11 4.551391e-08
BIRC3 3.851648e-09 3.978752e-06
IL2 8.886857e-08 6.885092e-05
SELE 2.475087e-07 1.534059e-04
BCL2L1 9.864902e-07 4.485631e-04

Kullback-Leibler (KL) divergence:

gene1 gene2 KLD KLD.p
DLGAP1 SOX2 9.08160044288928 0.001842360444131
MYC WDR36 8.27935400426403 0.002225292942782
MYC SFMBT1 8.27767843611966 0.002226212776101
CYP17A1 NFIC 8.0767423217575 0.00234076542414
PRF1 STAT3 8.04440062134892 0.002360021079851
JUN NOS2 8.03554034015082 0.002365337512273
NOS2 RELA 7.59128947444795 0.002656597252669
FOS NOS2 7.4782755495627 0.0027392172276

About NOS2: “Up-Regulation of iNOS in AML Blasts Creates an Immunosuppressive Microenvironment, Inhibits T-Cell Proliferation and Transforms T-Cells Towards a Tumor-Tolerating Phenotype”

In myeloid cells, the NF-κB complexes that bind to the nos2 promoter are p65/p65 and p50/p50 homodimers

29.03.2022

Downloading TCGA methylomes Running the RNAseq pipeline on PTBP1 data

30.03.2022

Trying to make a pchic network of genes of interest. Idea: Instead of 1 pchic w/ genes/tfs of interest + DMP/DMR -> 1 pchic w/ genes/tf of interest -> 1 pchic w/ DMR/DMP